EN
TradingView
Upgrade Upgrade now Start free trial Upgrade plan Pay nothing extra Upgrade early Get 6 months free Use last chance Get a month for $1
Markets US Stocks Health Technology Pharmaceuticals: Major

AgeX Therapeutics, Inc
AGE NYSE ARCA & MKT

AGE
AgeX Therapeutics, Inc NYSE ARCA & MKT
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now
Overview
Ideas Technicals Financials

AGE Stock Chart

Ideas

Videos only
AgeX Therapeutics and Sernova to Collaborate
AGE
, 60
AGE: AgeX Therapeutics and Sernova to Collaborate

AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A investors.agexinc.com

AGEX Therapeutics Channel trade
AGE
, 1D
Long
AGE: AGEX Therapeutics Channel trade

Well defined channel trade setup./ AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.

Bnaderín AGE¿?
AGE
, 1D
AGE: Bnaderín AGE¿?

.

Banderin
AGE
, 1D
AGE: Banderin

.

AGE: Age Reversal Technology in Human Cells
AGE
, 1D
Long
AGE: AGE: Age Reversal Technology in Human Cells

To General People The same genes responsible for regrowing new limbs after amputation of a salamander exist in your body right now. It's turned off after a few days during fetal development and replaced with the scar gene, a possible vascular survival mechanism of mammalian evolution. Leonard Hayflick limit shows death is inevitable via cell division...

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter